1. Home
  2. PACB vs RGR Comparison

PACB vs RGR Comparison

Compare PACB & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • RGR
  • Stock Information
  • Founded
  • PACB 2000
  • RGR 1949
  • Country
  • PACB United States
  • RGR United States
  • Employees
  • PACB N/A
  • RGR N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • RGR Ordnance And Accessories
  • Sector
  • PACB Industrials
  • RGR Industrials
  • Exchange
  • PACB Nasdaq
  • RGR Nasdaq
  • Market Cap
  • PACB 462.1M
  • RGR 553.4M
  • IPO Year
  • PACB 2010
  • RGR N/A
  • Fundamental
  • Price
  • PACB $1.34
  • RGR $34.54
  • Analyst Decision
  • PACB Buy
  • RGR
  • Analyst Count
  • PACB 7
  • RGR 0
  • Target Price
  • PACB $1.90
  • RGR N/A
  • AVG Volume (30 Days)
  • PACB 7.2M
  • RGR 191.0K
  • Earning Date
  • PACB 08-07-2025
  • RGR 07-30-2025
  • Dividend Yield
  • PACB N/A
  • RGR 2.03%
  • EPS Growth
  • PACB N/A
  • RGR N/A
  • EPS
  • PACB N/A
  • RGR 0.35
  • Revenue
  • PACB $156,110,000.00
  • RGR $536,291,000.00
  • Revenue This Year
  • PACB $5.26
  • RGR N/A
  • Revenue Next Year
  • PACB $16.13
  • RGR $3.39
  • P/E Ratio
  • PACB N/A
  • RGR $99.64
  • Revenue Growth
  • PACB N/A
  • RGR 3.31
  • 52 Week Low
  • PACB $0.85
  • RGR $31.64
  • 52 Week High
  • PACB $2.72
  • RGR $42.76
  • Technical
  • Relative Strength Index (RSI)
  • PACB 50.23
  • RGR 52.87
  • Support Level
  • PACB $1.21
  • RGR $34.73
  • Resistance Level
  • PACB $1.40
  • RGR $35.18
  • Average True Range (ATR)
  • PACB 0.09
  • RGR 0.62
  • MACD
  • PACB 0.01
  • RGR 0.19
  • Stochastic Oscillator
  • PACB 73.81
  • RGR 84.82

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

Share on Social Networks: